1440. Potential Impact of Routine Use of 13-Valent Pneumococcal Conjugate Vaccine on Hospitalizations for Pneumonia among Older Adults in Canada

BACKGROUND: In Canada, 13-valent pneumococcal conjugate vaccine (PCV13) was licensed for the prevention of vaccine-type (VT) pneumonia in adults in July 2015. Herd effects stemming from the routine pediatric PCV13 program have historically led to reductions in VT disease in older adults, and there i...

Descripción completa

Detalles Bibliográficos
Autores principales: Vojicic, Jelena, Dion, Stephane, Isturiz, Raúl E, Laferriere, Craig, Major, Maria, Nepal, Rajeev M, Suaya, Jose A, McLaughlin, John M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6252882/
http://dx.doi.org/10.1093/ofid/ofy210.1271

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6252882/
http://dx.doi.org/10.1093/ofid/ofy210.1271

Ejemplares similares